首页 > 最新文献

JMIR AI最新文献

英文 中文
Identifying Frailty in Older Adults Receiving Home Care Assessment Using Machine Learning: Longitudinal Observational Study on the Role of Classifier, Feature Selection, and Sample Size. 利用机器学习识别接受家庭护理评估的老年人的虚弱程度:关于分类器、特征选择和样本量作用的纵向观察研究。
Pub Date : 2024-01-31 DOI: 10.2196/44185
Cheng Pan, Hao Luo, Gary Cheung, Huiquan Zhou, Reynold Cheng, Sarah Cullum, Chuan Wu

Background: Machine learning techniques are starting to be used in various health care data sets to identify frail persons who may benefit from interventions. However, evidence about the performance of machine learning techniques compared to conventional regression is mixed. It is also unclear what methodological and database factors are associated with performance.

Objective: This study aimed to compare the mortality prediction accuracy of various machine learning classifiers for identifying frail older adults in different scenarios.

Methods: We used deidentified data collected from older adults (65 years of age and older) assessed with interRAI-Home Care instrument in New Zealand between January 1, 2012, and December 31, 2016. A total of 138 interRAI assessment items were used to predict 6-month and 12-month mortality, using 3 machine learning classifiers (random forest [RF], extreme gradient boosting [XGBoost], and multilayer perceptron [MLP]) and regularized logistic regression. We conducted a simulation study comparing the performance of machine learning models with logistic regression and interRAI Home Care Frailty Scale and examined the effects of sample sizes, the number of features, and train-test split ratios.

Results: A total of 95,042 older adults (median age 82.66 years, IQR 77.92-88.76; n=37,462, 39.42% male) receiving home care were analyzed. The average area under the curve (AUC) and sensitivities of 6-month mortality prediction showed that machine learning classifiers did not outperform regularized logistic regressions. In terms of AUC, regularized logistic regression had better performance than XGBoost, MLP, and RF when the number of features was ≤80 and the sample size ≤16,000; MLP outperformed regularized logistic regression in terms of sensitivities when the number of features was ≥40 and the sample size ≥4000. Conversely, RF and XGBoost demonstrated higher specificities than regularized logistic regression in all scenarios.

Conclusions: The study revealed that machine learning models exhibited significant variation in prediction performance when evaluated using different metrics. Regularized logistic regression was an effective model for identifying frail older adults receiving home care, as indicated by the AUC, particularly when the number of features and sample sizes were not excessively large. Conversely, MLP displayed superior sensitivity, while RF exhibited superior specificity when the number of features and sample sizes were large.

背景:机器学习技术已开始用于各种医疗数据集,以识别可能受益于干预措施的体弱者。然而,与传统回归法相比,机器学习技术的性能参差不齐。目前还不清楚哪些方法和数据库因素与机器学习技术的性能有关:本研究旨在比较各种机器学习分类器在不同情况下识别虚弱老年人的死亡率预测准确性:我们使用了从 2012 年 1 月 1 日至 2016 年 12 月 31 日期间在新西兰使用 interRAI-Home Care 仪器评估的老年人(65 岁及以上)的去身份化数据。我们使用 3 种机器学习分类器(随机森林 [RF]、极梯度提升 [XGBoost] 和多层感知器 [MLP])和正则化逻辑回归,对总共 138 个 interRAI 评估项目预测 6 个月和 12 个月的死亡率。我们进行了一项模拟研究,比较了机器学习模型与逻辑回归和 interRAI 家庭护理虚弱量表的性能,并考察了样本大小、特征数量和训练-测试分割比率的影响:共分析了 95,042 名接受家庭护理的老年人(中位年龄 82.66 岁,IQR 77.92-88.76;n=37,462,39.42% 为男性)。6 个月死亡率预测的平均曲线下面积(AUC)和灵敏度显示,机器学习分类器的效果并不优于正则化逻辑回归。就AUC而言,当特征数≤80且样本量≤16000时,正则化逻辑回归的性能优于XGBoost、MLP和RF;当特征数≥40且样本量≥4000时,MLP的灵敏度优于正则化逻辑回归。相反,RF 和 XGBoost 在所有情况下都比正则逻辑回归表现出更高的特异性:研究表明,在使用不同指标进行评估时,机器学习模型在预测性能方面表现出显著差异。从 AUC 值来看,正则化逻辑回归是识别接受家庭护理的体弱老年人的有效模型,尤其是在特征数量和样本量不过大的情况下。相反,当特征数量和样本量较大时,MLP 表现出更高的灵敏度,而 RF 则表现出更高的特异性。
{"title":"Identifying Frailty in Older Adults Receiving Home Care Assessment Using Machine Learning: Longitudinal Observational Study on the Role of Classifier, Feature Selection, and Sample Size.","authors":"Cheng Pan, Hao Luo, Gary Cheung, Huiquan Zhou, Reynold Cheng, Sarah Cullum, Chuan Wu","doi":"10.2196/44185","DOIUrl":"10.2196/44185","url":null,"abstract":"<p><strong>Background: </strong>Machine learning techniques are starting to be used in various health care data sets to identify frail persons who may benefit from interventions. However, evidence about the performance of machine learning techniques compared to conventional regression is mixed. It is also unclear what methodological and database factors are associated with performance.</p><p><strong>Objective: </strong>This study aimed to compare the mortality prediction accuracy of various machine learning classifiers for identifying frail older adults in different scenarios.</p><p><strong>Methods: </strong>We used deidentified data collected from older adults (65 years of age and older) assessed with interRAI-Home Care instrument in New Zealand between January 1, 2012, and December 31, 2016. A total of 138 interRAI assessment items were used to predict 6-month and 12-month mortality, using 3 machine learning classifiers (random forest [RF], extreme gradient boosting [XGBoost], and multilayer perceptron [MLP]) and regularized logistic regression. We conducted a simulation study comparing the performance of machine learning models with logistic regression and interRAI Home Care Frailty Scale and examined the effects of sample sizes, the number of features, and train-test split ratios.</p><p><strong>Results: </strong>A total of 95,042 older adults (median age 82.66 years, IQR 77.92-88.76; n=37,462, 39.42% male) receiving home care were analyzed. The average area under the curve (AUC) and sensitivities of 6-month mortality prediction showed that machine learning classifiers did not outperform regularized logistic regressions. In terms of AUC, regularized logistic regression had better performance than XGBoost, MLP, and RF when the number of features was ≤80 and the sample size ≤16,000; MLP outperformed regularized logistic regression in terms of sensitivities when the number of features was ≥40 and the sample size ≥4000. Conversely, RF and XGBoost demonstrated higher specificities than regularized logistic regression in all scenarios.</p><p><strong>Conclusions: </strong>The study revealed that machine learning models exhibited significant variation in prediction performance when evaluated using different metrics. Regularized logistic regression was an effective model for identifying frail older adults receiving home care, as indicated by the AUC, particularly when the number of features and sample sizes were not excessively large. Conversely, MLP displayed superior sensitivity, while RF exhibited superior specificity when the number of features and sample sizes were large.</p>","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"3 ","pages":"e44185"},"PeriodicalIF":0.0,"publicationDate":"2024-01-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11041467/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141322103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Environmental Uncertainty Perception Framework for Misinformation Detection and Spread Prediction in the COVID-19 Pandemic: Artificial Intelligence Approach 用于 COVID-19 大流行中错误信息检测和传播预测的环境不确定性感知框架:人工智能方法
Pub Date : 2024-01-29 DOI: 10.2196/47240
Jiahui Lu, Huibin Zhang, Yi Xiao, Yingyu Wang
Amidst the COVID-19 pandemic, misinformation on social media has posed significant threats to public health. Detecting and predicting the spread of misinformation are crucial for mitigating its adverse effects. However, prevailing frameworks for these tasks have predominantly focused on post-level signals of misinformation, neglecting features of the broader information environment where misinformation originates and proliferates. This study aims to create a novel framework that integrates the uncertainty of the information environment into misinformation features, with the goal of enhancing the model’s accuracy in tasks such as misinformation detection and predicting the scale of dissemination. The objective is to provide better support for online governance efforts during health crises. In this study, we embraced uncertainty features within the information environment and introduced a novel Environmental Uncertainty Perception (EUP) framework for the detection of misinformation and the prediction of its spread on social media. The framework encompasses uncertainty at 4 scales of the information environment: physical environment, macro-media environment, micro-communicative environment, and message framing. We assessed the effectiveness of the EUP using real-world COVID-19 misinformation data sets. The experimental results demonstrated that the EUP alone achieved notably good performance, with detection accuracy at 0.753 and prediction accuracy at 0.71. These results were comparable to state-of-the-art baseline models such as bidirectional long short-term memory (BiLSTM; detection accuracy 0.733 and prediction accuracy 0.707) and bidirectional encoder representations from transformers (BERT; detection accuracy 0.755 and prediction accuracy 0.728). Additionally, when the baseline models collaborated with the EUP, they exhibited improved accuracy by an average of 1.98% for the misinformation detection and 2.4% for spread-prediction tasks. On unbalanced data sets, the EUP yielded relative improvements of 21.5% and 5.7% in macro-F1-score and area under the curve, respectively. This study makes a significant contribution to the literature by recognizing uncertainty features within information environments as a crucial factor for improving misinformation detection and spread-prediction algorithms during the pandemic. The research elaborates on the complexities of uncertain information environments for misinformation across 4 distinct scales, including the physical environment, macro-media environment, micro-communicative environment, and message framing. The findings underscore the effectiveness of incorporating uncertainty into misinformation detection and spread prediction, providing an interdisciplinary and easily implementable framework for the field.
在 COVID-19 大流行期间,社交媒体上的错误信息对公众健康构成了重大威胁。检测和预测错误信息的传播对于减轻其不利影响至关重要。然而,针对这些任务的现有框架主要关注的是错误信息的后级信号,而忽视了错误信息起源和扩散的更广泛信息环境的特征。 本研究旨在创建一个新颖的框架,将信息环境的不确定性整合到错误信息特征中,目的是提高模型在错误信息检测和预测传播规模等任务中的准确性。其目的是为健康危机期间的在线治理工作提供更好的支持。 在这项研究中,我们考虑了信息环境中的不确定性特征,并引入了一个新颖的环境不确定性感知(EUP)框架,用于检测错误信息并预测其在社交媒体上的传播。该框架包括信息环境中四个尺度的不确定性:物理环境、宏观媒体环境、微观传播环境和信息框架。我们利用真实世界中的 COVID-19 错误信息数据集评估了 EUP 的有效性。 实验结果表明,EUP 本身的性能非常出色,其检测准确率为 0.753,预测准确率为 0.71。这些结果与最先进的基线模型不相上下,如双向长短期记忆(BiLSTM;检测准确率为 0.733,预测准确率为 0.707)和来自变压器的双向编码器表征(BERT;检测准确率为 0.755,预测准确率为 0.728)。此外,当基线模型与 EUP 协作时,它们在错误信息检测和传播预测任务中的准确率平均分别提高了 1.98% 和 2.4%。在非平衡数据集上,EUP 在宏观 F1 分数和曲线下面积方面分别取得了 21.5% 和 5.7% 的相对改进。 这项研究认识到信息环境中的不确定性特征是改进大流行病期间错误信息检测和传播预测算法的关键因素,从而为文献做出了重要贡献。研究阐述了错误信息的不确定信息环境的复杂性,包括物理环境、宏观媒体环境、微观交流环境和信息框架等 4 个不同尺度。研究结果强调了将不确定性纳入错误信息检测和传播预测的有效性,为该领域提供了一个跨学科且易于实施的框架。
{"title":"An Environmental Uncertainty Perception Framework for Misinformation Detection and Spread Prediction in the COVID-19 Pandemic: Artificial Intelligence Approach","authors":"Jiahui Lu, Huibin Zhang, Yi Xiao, Yingyu Wang","doi":"10.2196/47240","DOIUrl":"https://doi.org/10.2196/47240","url":null,"abstract":"\u0000 \u0000 Amidst the COVID-19 pandemic, misinformation on social media has posed significant threats to public health. Detecting and predicting the spread of misinformation are crucial for mitigating its adverse effects. However, prevailing frameworks for these tasks have predominantly focused on post-level signals of misinformation, neglecting features of the broader information environment where misinformation originates and proliferates.\u0000 \u0000 \u0000 \u0000 This study aims to create a novel framework that integrates the uncertainty of the information environment into misinformation features, with the goal of enhancing the model’s accuracy in tasks such as misinformation detection and predicting the scale of dissemination. The objective is to provide better support for online governance efforts during health crises.\u0000 \u0000 \u0000 \u0000 In this study, we embraced uncertainty features within the information environment and introduced a novel Environmental Uncertainty Perception (EUP) framework for the detection of misinformation and the prediction of its spread on social media. The framework encompasses uncertainty at 4 scales of the information environment: physical environment, macro-media environment, micro-communicative environment, and message framing. We assessed the effectiveness of the EUP using real-world COVID-19 misinformation data sets.\u0000 \u0000 \u0000 \u0000 The experimental results demonstrated that the EUP alone achieved notably good performance, with detection accuracy at 0.753 and prediction accuracy at 0.71. These results were comparable to state-of-the-art baseline models such as bidirectional long short-term memory (BiLSTM; detection accuracy 0.733 and prediction accuracy 0.707) and bidirectional encoder representations from transformers (BERT; detection accuracy 0.755 and prediction accuracy 0.728). Additionally, when the baseline models collaborated with the EUP, they exhibited improved accuracy by an average of 1.98% for the misinformation detection and 2.4% for spread-prediction tasks. On unbalanced data sets, the EUP yielded relative improvements of 21.5% and 5.7% in macro-F1-score and area under the curve, respectively.\u0000 \u0000 \u0000 \u0000 This study makes a significant contribution to the literature by recognizing uncertainty features within information environments as a crucial factor for improving misinformation detection and spread-prediction algorithms during the pandemic. The research elaborates on the complexities of uncertain information environments for misinformation across 4 distinct scales, including the physical environment, macro-media environment, micro-communicative environment, and message framing. The findings underscore the effectiveness of incorporating uncertainty into misinformation detection and spread prediction, providing an interdisciplinary and easily implementable framework for the field.\u0000","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"70 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140486335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Ethics in Developing AI-Based Applications in Medicine: Insights From Expert Interviews and Discussion of Implications 伦理在开发基于人工智能的医学应用中的作用:专家访谈的启示及影响讨论
Pub Date : 2024-01-12 DOI: 10.2196/51204
Lukas Weidener, Michael Fischer
The integration of artificial intelligence (AI)–based applications in the medical field has increased significantly, offering potential improvements in patient care and diagnostics. However, alongside these advancements, there is growing concern about ethical considerations, such as bias, informed consent, and trust in the development of these technologies. This study aims to assess the role of ethics in the development of AI-based applications in medicine. Furthermore, this study focuses on the potential consequences of neglecting ethical considerations in AI development, particularly their impact on patients and physicians. Qualitative content analysis was used to analyze the responses from expert interviews. Experts were selected based on their involvement in the research or practical development of AI-based applications in medicine for at least 5 years, leading to the inclusion of 7 experts in the study. The analysis revealed 3 main categories and 7 subcategories reflecting a wide range of views on the role of ethics in AI development. This variance underscores the subjectivity and complexity of integrating ethics into the development of AI in medicine. Although some experts view ethics as fundamental, others prioritize performance and efficiency, with some perceiving ethics as potential obstacles to technological progress. This dichotomy of perspectives clearly emphasizes the subjectivity and complexity surrounding the role of ethics in AI development, reflecting the inherent multifaceted nature of this issue. Despite the methodological limitations impacting the generalizability of the results, this study underscores the critical importance of consistent and integrated ethical considerations in AI development for medical applications. It advocates further research into effective strategies for ethical AI development, emphasizing the need for transparent and responsible practices, consideration of diverse data sources, physician training, and the establishment of comprehensive ethical and legal frameworks.
以人工智能(AI)为基础的应用在医疗领域的应用大幅增加,为患者护理和诊断提供了潜在的改进。然而,在取得这些进步的同时,人们也越来越关注这些技术开发过程中的伦理问题,如偏见、知情同意和信任。 本研究旨在评估伦理在开发基于人工智能的医学应用中的作用。此外,本研究还关注了在人工智能开发过程中忽视伦理因素的潜在后果,尤其是对患者和医生的影响。 本研究采用定性内容分析法对专家访谈的回答进行分析。选择专家的依据是他们参与基于人工智能的医学应用的研究或实际开发至少 5 年,最终有 7 位专家参与了研究。 分析显示了 3 个主要类别和 7 个子类别,反映了对伦理在人工智能发展中的作用的广泛看法。这种差异凸显了将伦理纳入人工智能医学发展的主观性和复杂性。虽然一些专家认为伦理是根本,但另一些专家则将性能和效率放在首位,还有一些专家认为伦理是技术进步的潜在障碍。这种观点上的对立清楚地强调了围绕伦理在人工智能发展中的作用的主观性和复杂性,反映了这一问题固有的多面性。 尽管研究方法上的局限性影响了研究结果的普遍性,但本研究强调了在医疗应用领域的人工智能开发过程中,始终如一地综合考虑伦理因素的极端重要性。它倡导进一步研究人工智能伦理开发的有效策略,强调需要透明和负责任的做法、考虑不同的数据来源、医生培训以及建立全面的伦理和法律框架。
{"title":"Role of Ethics in Developing AI-Based Applications in Medicine: Insights From Expert Interviews and Discussion of Implications","authors":"Lukas Weidener, Michael Fischer","doi":"10.2196/51204","DOIUrl":"https://doi.org/10.2196/51204","url":null,"abstract":"\u0000 \u0000 The integration of artificial intelligence (AI)–based applications in the medical field has increased significantly, offering potential improvements in patient care and diagnostics. However, alongside these advancements, there is growing concern about ethical considerations, such as bias, informed consent, and trust in the development of these technologies.\u0000 \u0000 \u0000 \u0000 This study aims to assess the role of ethics in the development of AI-based applications in medicine. Furthermore, this study focuses on the potential consequences of neglecting ethical considerations in AI development, particularly their impact on patients and physicians.\u0000 \u0000 \u0000 \u0000 Qualitative content analysis was used to analyze the responses from expert interviews. Experts were selected based on their involvement in the research or practical development of AI-based applications in medicine for at least 5 years, leading to the inclusion of 7 experts in the study.\u0000 \u0000 \u0000 \u0000 The analysis revealed 3 main categories and 7 subcategories reflecting a wide range of views on the role of ethics in AI development. This variance underscores the subjectivity and complexity of integrating ethics into the development of AI in medicine. Although some experts view ethics as fundamental, others prioritize performance and efficiency, with some perceiving ethics as potential obstacles to technological progress. This dichotomy of perspectives clearly emphasizes the subjectivity and complexity surrounding the role of ethics in AI development, reflecting the inherent multifaceted nature of this issue.\u0000 \u0000 \u0000 \u0000 Despite the methodological limitations impacting the generalizability of the results, this study underscores the critical importance of consistent and integrated ethical considerations in AI development for medical applications. It advocates further research into effective strategies for ethical AI development, emphasizing the need for transparent and responsible practices, consideration of diverse data sources, physician training, and the establishment of comprehensive ethical and legal frameworks.\u0000","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"32 11","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140509997","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Predictive Performance of Machine Learning-Based Models for Poststroke Clinical Outcomes in Comparison With Conventional Prognostic Scores: Multicenter, Hospital-Based Observational Study. 基于机器学习的中风后临床结局预测模型与传统预后评分的比较:基于医院的多中心观察研究。
Pub Date : 2024-01-11 DOI: 10.2196/46840
Fumi Irie, Koutarou Matsumoto, Ryu Matsuo, Yasunobu Nohara, Yoshinobu Wakisaka, Tetsuro Ago, Naoki Nakashima, Takanari Kitazono, Masahiro Kamouchi

Background: Although machine learning is a promising tool for making prognoses, the performance of machine learning in predicting outcomes after stroke remains to be examined.

Objective: This study aims to examine how much data-driven models with machine learning improve predictive performance for poststroke outcomes compared with conventional stroke prognostic scores and to elucidate how explanatory variables in machine learning-based models differ from the items of the stroke prognostic scores.

Methods: We used data from 10,513 patients who were registered in a multicenter prospective stroke registry in Japan between 2007 and 2017. The outcomes were poor functional outcome (modified Rankin Scale score >2) and death at 3 months after stroke. Machine learning-based models were developed using all variables with regularization methods, random forests, or boosted trees. We selected 3 stroke prognostic scores, namely, ASTRAL (Acute Stroke Registry and Analysis of Lausanne), PLAN (preadmission comorbidities, level of consciousness, age, neurologic deficit), and iScore (Ischemic Stroke Predictive Risk Score) for comparison. Item-based regression models were developed using the items of these 3 scores. The model performance was assessed in terms of discrimination and calibration. To compare the predictive performance of the data-driven model with that of the item-based model, we performed internal validation after random splits of identical populations into 80% of patients as a training set and 20% of patients as a test set; the models were developed in the training set and were validated in the test set. We evaluated the contribution of each variable to the models and compared the predictors used in the machine learning-based models with the items of the stroke prognostic scores.

Results: The mean age of the study patients was 73.0 (SD 12.5) years, and 59.1% (6209/10,513) of them were men. The area under the receiver operating characteristic curves and the area under the precision-recall curves for predicting poststroke outcomes were higher for machine learning-based models than for item-based models in identical populations after random splits. Machine learning-based models also performed better than item-based models in terms of the Brier score. Machine learning-based models used different explanatory variables, such as laboratory data, from the items of the conventional stroke prognostic scores. Including these data in the machine learning-based models as explanatory variables improved performance in predicting outcomes after stroke, especially poststroke death.

Conclusions: Machine learning-based models performed better in predicting poststroke outcomes than regression models using the items of conventional stroke prognostic scores, although they required additional variables, such as laboratory data, to attain improved performance. Furt

背景:尽管机器学习是一种很有前途的预后工具,但它在预测中风后预后方面的表现仍有待检验:尽管机器学习是一种很有前途的预后工具,但机器学习在预测卒中后预后方面的表现仍有待研究:本研究旨在探讨与传统卒中预后评分相比,机器学习数据驱动模型在多大程度上提高了卒中后预后的预测性能,并阐明基于机器学习的模型中的解释变量与卒中预后评分项目有何不同:我们使用了 2007 年至 2017 年期间在日本多中心前瞻性卒中登记处登记的 10513 名患者的数据。卒中后 3 个月的预后为不良功能预后(改良 Rankin 量表评分大于 2 分)和死亡。我们使用正则化方法、随机森林或助推树等所有变量开发了基于机器学习的模型。我们选择了 3 个卒中预后评分,即 ASTRAL(洛桑急性卒中登记与分析)、PLAN(入院前合并症、意识水平、年龄、神经功能缺损)和 iScore(缺血性卒中预测风险评分)进行比较。利用这三种评分的项目建立了基于项目的回归模型。模型的性能从区分度和校准方面进行了评估。为了比较数据驱动模型和基于项目的模型的预测性能,我们将相同的人群随机分成 80% 的患者作为训练集,20% 的患者作为测试集,然后进行内部验证;模型在训练集中开发,在测试集中验证。我们评估了每个变量对模型的贡献,并将基于机器学习的模型中使用的预测因子与中风预后评分项目进行了比较:研究患者的平均年龄为 73.0 岁(标准差为 12.5 岁),其中 59.1%(6209/10513)为男性。在随机拆分后的相同人群中,基于机器学习的模型预测卒中后预后的接收者操作特征曲线下面积和精确度-召回曲线下面积均高于基于项目的模型。在 Brier 评分方面,基于机器学习的模型也优于基于项目的模型。基于机器学习的模型使用了与传统卒中预后评分项目不同的解释变量,如实验室数据。在基于机器学习的模型中加入这些数据作为解释变量,可提高预测中风后预后的性能,尤其是中风后死亡:基于机器学习的模型在预测卒中后预后方面的表现优于使用传统卒中预后评分项目的回归模型,尽管它们需要额外的变量(如实验室数据)才能达到更好的效果。需要进一步研究以验证机器学习在临床环境中的实用性。
{"title":"Predictive Performance of Machine Learning-Based Models for Poststroke Clinical Outcomes in Comparison With Conventional Prognostic Scores: Multicenter, Hospital-Based Observational Study.","authors":"Fumi Irie, Koutarou Matsumoto, Ryu Matsuo, Yasunobu Nohara, Yoshinobu Wakisaka, Tetsuro Ago, Naoki Nakashima, Takanari Kitazono, Masahiro Kamouchi","doi":"10.2196/46840","DOIUrl":"10.2196/46840","url":null,"abstract":"<p><strong>Background: </strong>Although machine learning is a promising tool for making prognoses, the performance of machine learning in predicting outcomes after stroke remains to be examined.</p><p><strong>Objective: </strong>This study aims to examine how much data-driven models with machine learning improve predictive performance for poststroke outcomes compared with conventional stroke prognostic scores and to elucidate how explanatory variables in machine learning-based models differ from the items of the stroke prognostic scores.</p><p><strong>Methods: </strong>We used data from 10,513 patients who were registered in a multicenter prospective stroke registry in Japan between 2007 and 2017. The outcomes were poor functional outcome (modified Rankin Scale score >2) and death at 3 months after stroke. Machine learning-based models were developed using all variables with regularization methods, random forests, or boosted trees. We selected 3 stroke prognostic scores, namely, ASTRAL (Acute Stroke Registry and Analysis of Lausanne), PLAN (preadmission comorbidities, level of consciousness, age, neurologic deficit), and iScore (Ischemic Stroke Predictive Risk Score) for comparison. Item-based regression models were developed using the items of these 3 scores. The model performance was assessed in terms of discrimination and calibration. To compare the predictive performance of the data-driven model with that of the item-based model, we performed internal validation after random splits of identical populations into 80% of patients as a training set and 20% of patients as a test set; the models were developed in the training set and were validated in the test set. We evaluated the contribution of each variable to the models and compared the predictors used in the machine learning-based models with the items of the stroke prognostic scores.</p><p><strong>Results: </strong>The mean age of the study patients was 73.0 (SD 12.5) years, and 59.1% (6209/10,513) of them were men. The area under the receiver operating characteristic curves and the area under the precision-recall curves for predicting poststroke outcomes were higher for machine learning-based models than for item-based models in identical populations after random splits. Machine learning-based models also performed better than item-based models in terms of the Brier score. Machine learning-based models used different explanatory variables, such as laboratory data, from the items of the conventional stroke prognostic scores. Including these data in the machine learning-based models as explanatory variables improved performance in predicting outcomes after stroke, especially poststroke death.</p><p><strong>Conclusions: </strong>Machine learning-based models performed better in predicting poststroke outcomes than regression models using the items of conventional stroke prognostic scores, although they required additional variables, such as laboratory data, to attain improved performance. Furt","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"3 ","pages":"e46840"},"PeriodicalIF":0.0,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11041492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141322056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Learning From International Comparators of National Medical Imaging Initiatives for AI Development: Multiphase Qualitative Study 向国家医学影像计划的国际比较者学习,促进人工智能发展:多阶段定性研究
Pub Date : 2024-01-04 DOI: 10.2196/51168
K. Karpathakis, E. Pencheon, D. Cushnan
The COVID-19 pandemic drove investment and research into medical imaging platforms to provide data to create artificial intelligence (AI) algorithms for the management of patients with COVID-19. Building on the success of England’s National COVID-19 Chest Imaging Database, the national digital policy body (NHSX) sought to create a generalized national medical imaging platform for the development, validation, and deployment of algorithms. This study aims to understand international use cases of medical imaging platforms for the development and implementation of algorithms to inform the creation of England’s national imaging platform. The National Health Service (NHS) AI Lab Policy and Strategy Team adopted a multiphased approach: (1) identification and prioritization of national AI imaging platforms; (2) Political, Economic, Social, Technological, Legal, and Environmental (PESTLE) factor analysis deep dive into national AI imaging platforms; (3) semistructured interviews with key stakeholders; (4) workshop on emerging themes and insights with the internal NHSX team; and (5) formulation of policy recommendations. International use cases of national AI imaging platforms (n=7) were prioritized for PESTLE factor analysis. Stakeholders (n=13) from the international use cases were interviewed. Themes (n=8) from the semistructured interviews, including interview quotes, were analyzed with workshop participants (n=5). The outputs of the deep dives, interviews, and workshop were synthesized thematically into 8 categories with 17 subcategories. On the basis of the insights from the international use cases, policy recommendations (n=12) were developed to support the NHS AI Lab in the design and development of the English national medical imaging platform. The creation of AI algorithms supporting technology and infrastructure such as platforms often occurs in isolation within countries, let alone between countries. This novel policy research project sought to bridge the gap by learning from the challenges, successes, and experience of England’s international counterparts. Policy recommendations based on international learnings focused on the demonstrable benefits of the platform to secure sustainable funding, validation of algorithms and infrastructure to support in situ deployment, and creating wraparound tools for nontechnical participants such as clinicians to engage with algorithm creation. As health care organizations increasingly adopt technological solutions, policy makers have a responsibility to ensure that initiatives are informed by learnings from both national and international initiatives as well as disseminating the outcomes of their work.
COVID-19 大流行推动了对医学影像平台的投资和研究,以提供数据创建人工智能 (AI) 算法,管理 COVID-19 患者。在英格兰国家 COVID-19 胸部成像数据库取得成功的基础上,国家数字政策机构(NHSX)试图创建一个通用的国家医学成像平台,用于开发、验证和部署算法。 本研究旨在了解医疗成像平台在开发和实施算法方面的国际用例,为创建英格兰国家成像平台提供参考。 国家卫生服务(NHS)人工智能实验室政策和战略团队采用了一种多阶段方法:(1)确定国家人工智能成像平台并排定优先顺序;(2)对国家人工智能成像平台进行政治、经济、社会、技术、法律和环境(PESTLE)因素分析深度挖掘;(3)对主要利益相关者进行半结构化访谈;(4)与 NHSX 内部团队就新出现的主题和见解进行研讨;以及(5)制定政策建议。 国家人工智能成像平台的国际用例(n=7)被优先用于 PESTLE 因子分析。对国际使用案例中的利益相关者(n=13)进行了访谈。与研讨会与会者(5 人)一起分析了半结构式访谈中的主题(8 个),包括访谈引语。深入研究、访谈和研讨会的成果按主题归纳为 8 个类别和 17 个子类别。根据从国际使用案例中获得的启示,制定了政策建议(n=12),以支持英国国家医疗服务系统人工智能实验室设计和开发英国国家医学影像平台。 支持平台等技术和基础设施的人工智能算法的创建往往是在国家内部孤立进行的,更不用说国家之间了。这项新颖的政策研究项目试图通过学习英格兰所面临的挑战、取得的成功以及国际同行的经验来弥补这一差距。根据国际经验提出的政策建议侧重于平台的可证明效益,以确保可持续的资金、算法和基础设施的验证以支持现场部署,以及为临床医生等非技术参与者创建参与算法创建的配套工具。随着医疗机构越来越多地采用技术解决方案,政策制定者有责任确保从国家和国际倡议中吸取经验教训,并传播其工作成果。
{"title":"Learning From International Comparators of National Medical Imaging Initiatives for AI Development: Multiphase Qualitative Study","authors":"K. Karpathakis, E. Pencheon, D. Cushnan","doi":"10.2196/51168","DOIUrl":"https://doi.org/10.2196/51168","url":null,"abstract":"\u0000 \u0000 The COVID-19 pandemic drove investment and research into medical imaging platforms to provide data to create artificial intelligence (AI) algorithms for the management of patients with COVID-19. Building on the success of England’s National COVID-19 Chest Imaging Database, the national digital policy body (NHSX) sought to create a generalized national medical imaging platform for the development, validation, and deployment of algorithms.\u0000 \u0000 \u0000 \u0000 This study aims to understand international use cases of medical imaging platforms for the development and implementation of algorithms to inform the creation of England’s national imaging platform.\u0000 \u0000 \u0000 \u0000 The National Health Service (NHS) AI Lab Policy and Strategy Team adopted a multiphased approach: (1) identification and prioritization of national AI imaging platforms; (2) Political, Economic, Social, Technological, Legal, and Environmental (PESTLE) factor analysis deep dive into national AI imaging platforms; (3) semistructured interviews with key stakeholders; (4) workshop on emerging themes and insights with the internal NHSX team; and (5) formulation of policy recommendations.\u0000 \u0000 \u0000 \u0000 International use cases of national AI imaging platforms (n=7) were prioritized for PESTLE factor analysis. Stakeholders (n=13) from the international use cases were interviewed. Themes (n=8) from the semistructured interviews, including interview quotes, were analyzed with workshop participants (n=5). The outputs of the deep dives, interviews, and workshop were synthesized thematically into 8 categories with 17 subcategories. On the basis of the insights from the international use cases, policy recommendations (n=12) were developed to support the NHS AI Lab in the design and development of the English national medical imaging platform.\u0000 \u0000 \u0000 \u0000 The creation of AI algorithms supporting technology and infrastructure such as platforms often occurs in isolation within countries, let alone between countries. This novel policy research project sought to bridge the gap by learning from the challenges, successes, and experience of England’s international counterparts. Policy recommendations based on international learnings focused on the demonstrable benefits of the platform to secure sustainable funding, validation of algorithms and infrastructure to support in situ deployment, and creating wraparound tools for nontechnical participants such as clinicians to engage with algorithm creation. As health care organizations increasingly adopt technological solutions, policy makers have a responsibility to ensure that initiatives are informed by learnings from both national and international initiatives as well as disseminating the outcomes of their work.\u0000","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"70 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139386106","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association Between Online Reviews of Substance Use Disorder Treatment Facilities and Drug-Induced Mortality Rates: Cross-Sectional Analysis 药物使用障碍治疗机构的在线评论与药物致死率之间的关系:横断面分析
Pub Date : 2023-12-29 DOI: 10.2196/46317
Matthew P. Abrams, R. Merchant, Zachary F. Meisel, Arthur P Pelullo, Sharath Chandra Guntuku, A. Agarwal
Drug-induced mortality across the United States has continued to rise. To date, there are limited measures to evaluate patient preferences and priorities regarding substance use disorder (SUD) treatment, and many patients do not have access to evidence-based treatment options. Patients and their families seeking SUD treatment may begin their search for an SUD treatment facility online, where they can find information about individual facilities, as well as a summary of patient-generated web-based reviews via popular platforms such as Google or Yelp. Web-based reviews of health care facilities may reflect information about factors associated with positive or negative patient satisfaction. The association between patient satisfaction with SUD treatment and drug-induced mortality is not well understood. The objective of this study was to examine the association between online review content of SUD treatment facilities and drug-induced state mortality. A cross-sectional analysis of online reviews and ratings of Substance Abuse and Mental Health Services Administration (SAMHSA)–designated SUD treatment facilities listed between September 2005 and October 2021 was conducted. The primary outcomes were (1) mean online rating of SUD treatment facilities from 1 star (worst) to 5 stars (best) and (2) average drug-induced mortality rates from the Centers for Disease Control and Prevention (CDC) WONDER Database (2006-2019). Clusters of words with differential frequencies within reviews were identified. A 3-level linear model was used to estimate the association between online review ratings and drug-induced mortality. A total of 589 SAMHSA-designated facilities (n=9597 reviews) were included in this study. Drug-induced mortality was compared with the average. Approximately half (24/47, 51%) of states had below average (“low”) mortality rates (mean 13.40, SD 2.45 deaths per 100,000 people), and half (23/47, 49%) had above average (“high”) drug-induced mortality rates (mean 21.92, SD 3.69 deaths per 100,000 people). The top 5 themes associated with low drug-induced mortality included detoxification and addiction rehabilitation services (r=0.26), gratitude for recovery (r=–0.25), thankful for treatment (r=–0.32), caring staff and amazing experience (r=–0.23), and individualized recovery programs (r=–0.20). The top 5 themes associated with high mortality were care from doctors or providers (r=0.24), rude and insensitive care (r=0.23), medication and prescriptions (r=0.22), front desk and reception experience (r=0.22), and dissatisfaction with communication (r=0.21). In the multilevel linear model, a state with a 10 deaths per 100,000 people increase in mortality was associated with a 0.30 lower average Yelp rating (P=.005). Lower online ratings of SUD treatment facilities were associated with higher drug-induced mortality at the state level. Elements of patient experience may be associated with state-level mortality. Identified themes
在美国,药物导致的死亡率持续上升。迄今为止,用于评估患者对药物使用障碍(SUD)治疗的偏好和优先级的措施十分有限,许多患者无法获得循证治疗方案。寻求药物滥用障碍治疗的患者及其家属可能会从网上开始寻找药物滥用障碍治疗机构,他们可以通过谷歌或 Yelp 等流行平台找到有关各个机构的信息以及患者提供的网络评论摘要。对医疗机构的网络评论可能会反映出与患者满意度相关的积极或消极因素的信息。患者对 SUD 治疗的满意度与药物引起的死亡率之间的关系尚不十分清楚。 本研究的目的是探讨吸毒成瘾治疗机构的在线评论内容与毒品导致的国家死亡率之间的关联。 本研究对 2005 年 9 月至 2021 年 10 月期间列出的药物滥用和心理健康服务管理局(SAMHSA)指定的药物滥用治疗机构的在线评论和评级进行了横截面分析。主要结果包括:(1)从 1 星(最差)到 5 星(最佳)的 SUD 治疗机构平均在线评分;(2)美国疾病控制和预防中心(CDC)WONDER 数据库(2006-2019 年)中的平均药物诱发死亡率。确定了评论中频率不同的词组。采用 3 级线性模型估算在线评论评级与药物致死率之间的关联。 本研究共纳入了 589 家 SAMHSA 指定机构(n=9597 篇评论)。药物导致的死亡率与平均值进行了比较。约有一半州(24/47,51%)的死亡率低于平均水平("低")(平均每 10 万人中有 13.40 人死亡,标准差为 2.45 人),有一半州(23/47,49%)的药物致死率高于平均水平("高")(平均每 10 万人中有 21.92 人死亡,标准差为 3.69 人)。与毒品导致的低死亡率相关的前 5 个主题包括:戒毒和戒毒康复服务(r=0.26)、对康复的感激之情(r=-0.25)、对治疗的感激之情(r=-0.32)、关怀备至的工作人员和令人惊叹的经历(r=-0.23)以及个性化康复计划(r=-0.20)。与高死亡率相关的前 5 个主题分别是医生或服务提供者的护理(r=0.24)、粗鲁和麻木不仁的护理(r=0.23)、药物和处方(r=0.22)、前台和接待体验(r=0.22)以及对沟通的不满意(r=0.21)。在多层次线性模型中,每 10 万人中死亡人数增加 10 人的州与 Yelp 平均评分降低 0.30 相关(P=0.005)。 在州一级,药物滥用治疗机构的在线评分较低与药物引起的死亡率较高有关。患者体验要素可能与州一级的死亡率有关。从在线有机衍生的患者内容中识别出的主题可以为改善高质量和以患者为中心的 SUD 护理提供参考。
{"title":"Association Between Online Reviews of Substance Use Disorder Treatment Facilities and Drug-Induced Mortality Rates: Cross-Sectional Analysis","authors":"Matthew P. Abrams, R. Merchant, Zachary F. Meisel, Arthur P Pelullo, Sharath Chandra Guntuku, A. Agarwal","doi":"10.2196/46317","DOIUrl":"https://doi.org/10.2196/46317","url":null,"abstract":"Drug-induced mortality across the United States has continued to rise. To date, there are limited measures to evaluate patient preferences and priorities regarding substance use disorder (SUD) treatment, and many patients do not have access to evidence-based treatment options. Patients and their families seeking SUD treatment may begin their search for an SUD treatment facility online, where they can find information about individual facilities, as well as a summary of patient-generated web-based reviews via popular platforms such as Google or Yelp. Web-based reviews of health care facilities may reflect information about factors associated with positive or negative patient satisfaction. The association between patient satisfaction with SUD treatment and drug-induced mortality is not well understood. The objective of this study was to examine the association between online review content of SUD treatment facilities and drug-induced state mortality. A cross-sectional analysis of online reviews and ratings of Substance Abuse and Mental Health Services Administration (SAMHSA)–designated SUD treatment facilities listed between September 2005 and October 2021 was conducted. The primary outcomes were (1) mean online rating of SUD treatment facilities from 1 star (worst) to 5 stars (best) and (2) average drug-induced mortality rates from the Centers for Disease Control and Prevention (CDC) WONDER Database (2006-2019). Clusters of words with differential frequencies within reviews were identified. A 3-level linear model was used to estimate the association between online review ratings and drug-induced mortality. A total of 589 SAMHSA-designated facilities (n=9597 reviews) were included in this study. Drug-induced mortality was compared with the average. Approximately half (24/47, 51%) of states had below average (“low”) mortality rates (mean 13.40, SD 2.45 deaths per 100,000 people), and half (23/47, 49%) had above average (“high”) drug-induced mortality rates (mean 21.92, SD 3.69 deaths per 100,000 people). The top 5 themes associated with low drug-induced mortality included detoxification and addiction rehabilitation services (r=0.26), gratitude for recovery (r=–0.25), thankful for treatment (r=–0.32), caring staff and amazing experience (r=–0.23), and individualized recovery programs (r=–0.20). The top 5 themes associated with high mortality were care from doctors or providers (r=0.24), rude and insensitive care (r=0.23), medication and prescriptions (r=0.22), front desk and reception experience (r=0.22), and dissatisfaction with communication (r=0.21). In the multilevel linear model, a state with a 10 deaths per 100,000 people increase in mortality was associated with a 0.30 lower average Yelp rating (P=.005). Lower online ratings of SUD treatment facilities were associated with higher drug-induced mortality at the state level. Elements of patient experience may be associated with state-level mortality. Identified themes ","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"52 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139145970","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Evolution of Artificial Intelligence in Biomedicine: Bibliometric Analysis 人工智能在生物医学中的发展:文献计量分析
Pub Date : 2023-12-19 DOI: 10.2196/45770
Jiasheng Gu, Chongyang Gao, Lili Wang
The utilization of artificial intelligence (AI) technologies in the biomedical field has attracted increasing attention in recent decades. Studying how past AI technologies have found their way into medicine over time can help to predict which current (and future) AI technologies have the potential to be utilized in medicine in the coming years, thereby providing a helpful reference for future research directions. The aim of this study was to predict the future trend of AI technologies used in different biomedical domains based on past trends of related technologies and biomedical domains. We collected a large corpus of articles from the PubMed database pertaining to the intersection of AI and biomedicine. Initially, we attempted to use regression on the extracted keywords alone; however, we found that this approach did not provide sufficient information. Therefore, we propose a method called “background-enhanced prediction” to expand the knowledge utilized by the regression algorithm by incorporating both the keywords and their surrounding context. This method of data construction resulted in improved performance across the six regression models evaluated. Our findings were confirmed through experiments on recurrent prediction and forecasting. In our analysis using background information for prediction, we found that a window size of 3 yielded the best results, outperforming the use of keywords alone. Furthermore, utilizing data only prior to 2017, our regression projections for the period of 2017-2021 exhibited a high coefficient of determination (R2), which reached up to 0.78, demonstrating the effectiveness of our method in predicting long-term trends. Based on the prediction, studies related to proteins and tumors will be pushed out of the top 20 and become replaced by early diagnostics, tomography, and other detection technologies. These are certain areas that are well-suited to incorporate AI technology. Deep learning, machine learning, and neural networks continue to be the dominant AI technologies in biomedical applications. Generative adversarial networks represent an emerging technology with a strong growth trend. In this study, we explored AI trends in the biomedical field and developed a predictive model to forecast future trends. Our findings were confirmed through experiments on current trends.
近几十年来,人工智能(AI)技术在生物医学领域的应用日益受到关注。研究过去的人工智能技术是如何随着时间的推移进入医学领域的,有助于预测当前(和未来)哪些人工智能技术有可能在未来几年被应用于医学领域,从而为未来的研究方向提供有益的参考。 本研究旨在根据相关技术和生物医学领域过去的发展趋势,预测人工智能技术在不同生物医学领域应用的未来趋势。 我们从 PubMed 数据库中收集了大量与人工智能和生物医学交叉相关的文章。起初,我们尝试仅对提取的关键词进行回归,但发现这种方法无法提供足够的信息。因此,我们提出了一种名为 "背景增强预测 "的方法,通过结合关键词及其周围上下文来扩展回归算法所利用的知识。这种数据构建方法提高了所评估的六个回归模型的性能。我们的研究结果在循环预测和预报实验中得到了证实。 在使用背景信息进行预测的分析中,我们发现窗口大小为 3 的结果最好,优于仅使用关键词的结果。此外,仅利用 2017 年之前的数据,我们对 2017-2021 年期间的回归预测显示出较高的决定系数(R2),高达 0.78,证明了我们的方法在预测长期趋势方面的有效性。根据预测,与蛋白质和肿瘤相关的研究将被挤出前 20 名,取而代之的是早期诊断、断层扫描和其他检测技术。这些领域非常适合采用人工智能技术。深度学习、机器学习和神经网络仍然是生物医学应用中的主流人工智能技术。生成对抗网络是一种新兴技术,具有强劲的增长趋势。 在本研究中,我们探讨了生物医学领域的人工智能趋势,并开发了一个预测模型来预测未来趋势。我们的研究结果通过对当前趋势的实验得到了证实。
{"title":"The Evolution of Artificial Intelligence in Biomedicine: Bibliometric Analysis","authors":"Jiasheng Gu, Chongyang Gao, Lili Wang","doi":"10.2196/45770","DOIUrl":"https://doi.org/10.2196/45770","url":null,"abstract":"\u0000 \u0000 The utilization of artificial intelligence (AI) technologies in the biomedical field has attracted increasing attention in recent decades. Studying how past AI technologies have found their way into medicine over time can help to predict which current (and future) AI technologies have the potential to be utilized in medicine in the coming years, thereby providing a helpful reference for future research directions.\u0000 \u0000 \u0000 \u0000 The aim of this study was to predict the future trend of AI technologies used in different biomedical domains based on past trends of related technologies and biomedical domains.\u0000 \u0000 \u0000 \u0000 We collected a large corpus of articles from the PubMed database pertaining to the intersection of AI and biomedicine. Initially, we attempted to use regression on the extracted keywords alone; however, we found that this approach did not provide sufficient information. Therefore, we propose a method called “background-enhanced prediction” to expand the knowledge utilized by the regression algorithm by incorporating both the keywords and their surrounding context. This method of data construction resulted in improved performance across the six regression models evaluated. Our findings were confirmed through experiments on recurrent prediction and forecasting.\u0000 \u0000 \u0000 \u0000 In our analysis using background information for prediction, we found that a window size of 3 yielded the best results, outperforming the use of keywords alone. Furthermore, utilizing data only prior to 2017, our regression projections for the period of 2017-2021 exhibited a high coefficient of determination (R2), which reached up to 0.78, demonstrating the effectiveness of our method in predicting long-term trends. Based on the prediction, studies related to proteins and tumors will be pushed out of the top 20 and become replaced by early diagnostics, tomography, and other detection technologies. These are certain areas that are well-suited to incorporate AI technology. Deep learning, machine learning, and neural networks continue to be the dominant AI technologies in biomedical applications. Generative adversarial networks represent an emerging technology with a strong growth trend.\u0000 \u0000 \u0000 \u0000 In this study, we explored AI trends in the biomedical field and developed a predictive model to forecast future trends. Our findings were confirmed through experiments on current trends.\u0000","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":" 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138962293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical Considerations and Applied Examples of Cross-Validation for Model Development and Evaluation in Health Care: Tutorial 医疗保健模型开发和评估中交叉验证的实际考虑因素和应用实例:教程
Pub Date : 2023-12-18 DOI: 10.2196/49023
Drew Wilimitis, Colin G Walsh
Cross-validation remains a popular means of developing and validating artificial intelligence for health care. Numerous subtypes of cross-validation exist. Although tutorials on this validation strategy have been published and some with applied examples, we present here a practical tutorial comparing multiple forms of cross-validation using a widely accessible, real-world electronic health care data set: Medical Information Mart for Intensive Care-III (MIMIC-III). This tutorial explored methods such as K-fold cross-validation and nested cross-validation, highlighting their advantages and disadvantages across 2 common predictive modeling use cases: classification (mortality) and regression (length of stay). We aimed to provide readers with reproducible notebooks and best practices for modeling with electronic health care data. We also described sets of useful recommendations as we demonstrated that nested cross-validation reduces optimistic bias but comes with additional computational challenges. This tutorial might improve the community’s understanding of these important methods while catalyzing the modeling community to apply these guides directly in their work using the published code.
交叉验证仍然是开发和验证医疗人工智能的常用方法。交叉验证有许多子类型。尽管有关这种验证策略的教程已经出版,其中一些还附有应用实例,但我们在此介绍一种实用的教程,它使用了可广泛访问的真实世界电子医疗数据集,对多种形式的交叉验证进行了比较:重症监护医疗信息市场-III(MIMIC-III)。本教程探讨了 K 折交叉验证和嵌套交叉验证等方法,突出了它们在分类(死亡率)和回归(住院时间)这两种常见预测建模用例中的优缺点。我们的目标是为读者提供可重现的笔记本以及利用电子医疗数据建模的最佳实践。我们还介绍了一些有用的建议,因为我们证明嵌套交叉验证可以减少乐观偏差,但也会带来额外的计算挑战。本教程可能会提高社区对这些重要方法的理解,同时促进建模社区在其工作中使用已发布的代码直接应用这些指南。
{"title":"Practical Considerations and Applied Examples of Cross-Validation for Model Development and Evaluation in Health Care: Tutorial","authors":"Drew Wilimitis, Colin G Walsh","doi":"10.2196/49023","DOIUrl":"https://doi.org/10.2196/49023","url":null,"abstract":"Cross-validation remains a popular means of developing and validating artificial intelligence for health care. Numerous subtypes of cross-validation exist. Although tutorials on this validation strategy have been published and some with applied examples, we present here a practical tutorial comparing multiple forms of cross-validation using a widely accessible, real-world electronic health care data set: Medical Information Mart for Intensive Care-III (MIMIC-III). This tutorial explored methods such as K-fold cross-validation and nested cross-validation, highlighting their advantages and disadvantages across 2 common predictive modeling use cases: classification (mortality) and regression (length of stay). We aimed to provide readers with reproducible notebooks and best practices for modeling with electronic health care data. We also described sets of useful recommendations as we demonstrated that nested cross-validation reduces optimistic bias but comes with additional computational challenges. This tutorial might improve the community’s understanding of these important methods while catalyzing the modeling community to apply these guides directly in their work using the published code.","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"28 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139175430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Machine Learning–Based Asthma Attack Prediction Models From Routinely Collected Electronic Health Records: Systematic Scoping Review 基于机器学习的哮喘发作预测模型来自常规收集的电子健康记录:系统性范围审查
Pub Date : 2023-12-07 DOI: 10.2196/46717
Arif Budiarto, K. C. Tsang, Andrew M Wilson, Aziz Sheikh, Syed Ahmar Shah
An early warning tool to predict attacks could enhance asthma management and reduce the likelihood of serious consequences. Electronic health records (EHRs) providing access to historical data about patients with asthma coupled with machine learning (ML) provide an opportunity to develop such a tool. Several studies have developed ML-based tools to predict asthma attacks. This study aims to critically evaluate ML-based models derived using EHRs for the prediction of asthma attacks. We systematically searched PubMed and Scopus (the search period was between January 1, 2012, and January 31, 2023) for papers meeting the following inclusion criteria: (1) used EHR data as the main data source, (2) used asthma attack as the outcome, and (3) compared ML-based prediction models’ performance. We excluded non-English papers and nonresearch papers, such as commentary and systematic review papers. In addition, we also excluded papers that did not provide any details about the respective ML approach and its result, including protocol papers. The selected studies were then summarized across multiple dimensions including data preprocessing methods, ML algorithms, model validation, model explainability, and model implementation. Overall, 17 papers were included at the end of the selection process. There was considerable heterogeneity in how asthma attacks were defined. Of the 17 studies, 8 (47%) studies used routinely collected data both from primary care and secondary care practices together. Extreme imbalanced data was a notable issue in most studies (13/17, 76%), but only 38% (5/13) of them explicitly dealt with it in their data preprocessing pipeline. The gradient boosting–based method was the best ML method in 59% (10/17) of the studies. Of the 17 studies, 14 (82%) studies used a model explanation method to identify the most important predictors. None of the studies followed the standard reporting guidelines, and none were prospectively validated. Our review indicates that this research field is still underdeveloped, given the limited body of evidence, heterogeneity of methods, lack of external validation, and suboptimally reported models. We highlighted several technical challenges (class imbalance, external validation, model explanation, and adherence to reporting guidelines to aid reproducibility) that need to be addressed to make progress toward clinical adoption.
预测哮喘发作的早期预警工具可以加强哮喘管理,减少发生严重后果的可能性。电子健康记录(EHRs)提供了对哮喘患者历史数据的访问,加上机器学习(ML),为开发此类工具提供了机会。一些研究开发了基于机器学习的工具来预测哮喘发作。本研究旨在批判性地评估基于ml的模型,这些模型使用电子病历来预测哮喘发作。我们系统检索PubMed和Scopus(检索期为2012年1月1日至2023年1月31日),寻找符合以下纳入标准的论文:(1)以电子病历数据为主要数据源,(2)以哮喘发作为结局,(3)比较基于ml的预测模型的性能。我们排除了非英文论文和非研究论文,如评论和系统综述论文。此外,我们还排除了未提供有关各自ML方法及其结果的任何详细信息的论文,包括协议论文。然后从多个维度对所选研究进行总结,包括数据预处理方法、ML算法、模型验证、模型可解释性和模型实现。在评选过程结束时,总共有17篇论文入选。在如何定义哮喘发作方面存在相当大的异质性。在这17项研究中,8项(47%)研究同时从初级保健和二级保健实践中常规收集数据。在大多数研究中(13/17,76%),数据极度不平衡是一个值得注意的问题,但只有38%(5/13)的研究在数据预处理管道中明确处理了这个问题。59%(10/17)的研究中,梯度增强法是最佳的ML方法。在17项研究中,14项(82%)研究使用模型解释方法来确定最重要的预测因子。没有一项研究遵循标准报告准则,也没有一项研究得到前瞻性验证。我们的综述表明,由于证据有限,方法异质性,缺乏外部验证,以及报告的模型不够理想,这一研究领域仍然不发达。我们强调了需要解决的几个技术挑战(类别不平衡、外部验证、模型解释和遵守报告指南以帮助可重复性),以使临床采用取得进展。
{"title":"Machine Learning–Based Asthma Attack Prediction Models From Routinely Collected Electronic Health Records: Systematic Scoping Review","authors":"Arif Budiarto, K. C. Tsang, Andrew M Wilson, Aziz Sheikh, Syed Ahmar Shah","doi":"10.2196/46717","DOIUrl":"https://doi.org/10.2196/46717","url":null,"abstract":"\u0000 \u0000 An early warning tool to predict attacks could enhance asthma management and reduce the likelihood of serious consequences. Electronic health records (EHRs) providing access to historical data about patients with asthma coupled with machine learning (ML) provide an opportunity to develop such a tool. Several studies have developed ML-based tools to predict asthma attacks.\u0000 \u0000 \u0000 \u0000 This study aims to critically evaluate ML-based models derived using EHRs for the prediction of asthma attacks.\u0000 \u0000 \u0000 \u0000 We systematically searched PubMed and Scopus (the search period was between January 1, 2012, and January 31, 2023) for papers meeting the following inclusion criteria: (1) used EHR data as the main data source, (2) used asthma attack as the outcome, and (3) compared ML-based prediction models’ performance. We excluded non-English papers and nonresearch papers, such as commentary and systematic review papers. In addition, we also excluded papers that did not provide any details about the respective ML approach and its result, including protocol papers. The selected studies were then summarized across multiple dimensions including data preprocessing methods, ML algorithms, model validation, model explainability, and model implementation.\u0000 \u0000 \u0000 \u0000 Overall, 17 papers were included at the end of the selection process. There was considerable heterogeneity in how asthma attacks were defined. Of the 17 studies, 8 (47%) studies used routinely collected data both from primary care and secondary care practices together. Extreme imbalanced data was a notable issue in most studies (13/17, 76%), but only 38% (5/13) of them explicitly dealt with it in their data preprocessing pipeline. The gradient boosting–based method was the best ML method in 59% (10/17) of the studies. Of the 17 studies, 14 (82%) studies used a model explanation method to identify the most important predictors. None of the studies followed the standard reporting guidelines, and none were prospectively validated.\u0000 \u0000 \u0000 \u0000 Our review indicates that this research field is still underdeveloped, given the limited body of evidence, heterogeneity of methods, lack of external validation, and suboptimally reported models. We highlighted several technical challenges (class imbalance, external validation, model explanation, and adherence to reporting guidelines to aid reproducibility) that need to be addressed to make progress toward clinical adoption.\u0000","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"17 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138592798","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Physicians' and Machine Learning Researchers’ Perspectives on Ethical Issues in the Development of Clinical Machine Learning Tools: A Qualitative Interview Study (Preprint) 医生和机器学习研究人员对临床机器学习工具开发中的伦理问题的看法:一项定性访谈研究(预印本)
Pub Date : 2023-10-30 DOI: 10.2196/47449
Jane Paik Kim, Katie Ryan, Max Kasun, Justin Hogg, Laura B. Dunn, Laura W. Roberts
Background Innovative tools leveraging artificial intelligence (AI) and machine learning (ML) are rapidly being developed for medicine, with new applications emerging in prediction, diagnosis, and treatment across a range of illnesses, patient populations, and clinical procedures. One barrier for successful innovation is the scarcity of research in the current literature seeking and analyzing the views of AI or ML researchers and physicians to support ethical guidance. Objective This study aims to describe, using a qualitative approach, the landscape of ethical issues that AI or ML researchers and physicians with professional exposure to AI or ML tools observe or anticipate in the development and use of AI and ML in medicine. Methods Semistructured interviews were used to facilitate in-depth, open-ended discussion, and a purposeful sampling technique was used to identify and recruit participants. We conducted 21 semistructured interviews with a purposeful sample of AI and ML researchers (n=10) and physicians (n=11). We asked interviewees about their views regarding ethical considerations related to the adoption of AI and ML in medicine. Interviews were transcribed and deidentified by members of our research team. Data analysis was guided by the principles of qualitative content analysis. This approach, in which transcribed data is broken down into descriptive units that are named and sorted based on their content, allows for the inductive emergence of codes directly from the data set. Results Notably, both researchers and physicians articulated concerns regarding how AI and ML innovations are shaped in their early development (ie, the problem formulation stage). Considerations encompassed the assessment of research priorities and motivations, clarity and centeredness of clinical needs, professional and demographic diversity of research teams, and interdisciplinary knowledge generation and collaboration. Phase-1 ethical issues identified by interviewees were notably interdisciplinary in nature and invited questions regarding how to align priorities and values across disciplines and ensure clinical value throughout the development and implementation of medical AI and ML. Relatedly, interviewees suggested interdisciplinary solutions to these issues, for example, more resources to support knowledge generation and collaboration between developers and physicians, engagement with a broader range of stakeholders, and efforts to increase diversity in research broadly and within individual teams. Conclusions These qualitative findings help elucidate several ethical challenges anticipated or encountered in AI and ML for health care. Our study is unique in that its use of open-ended questions allowed interviewees to explore their sentiments and perspectives without overreliance on implicit assumptions about what AI and ML currently are or are not. This analysis, however, does not include the perspectives of other relevant stakeholder groups, such as patients
利用人工智能(AI)和机器学习(ML)的创新工具正在迅速开发用于医学,在一系列疾病、患者群体和临床程序的预测、诊断和治疗方面出现了新的应用。成功创新的一个障碍是,目前文献中缺乏寻求和分析人工智能或机器学习研究人员和医生的观点以支持伦理指导的研究。本研究旨在使用定性方法描述人工智能或机器学习研究人员和专业接触人工智能或机器学习工具的医生在医学中开发和使用人工智能和机器学习时观察或预测的伦理问题。方法采用半结构化访谈,促进深入、开放式的讨论,并采用有目的的抽样技术来识别和招募参与者。我们对人工智能和机器学习研究人员(n=10)和医生(n=11)进行了21次半结构化访谈。我们询问了受访者对在医学中采用人工智能和机器学习的伦理考虑的看法。访谈由我们的研究团队成员进行转录和鉴定。数据分析以定性内容分析原则为指导。这种方法将转录的数据分解为描述性单元,并根据其内容进行命名和排序,从而允许直接从数据集中归纳出代码。值得注意的是,研究人员和医生都表达了对人工智能和机器学习创新在早期发展(即问题制定阶段)如何形成的担忧。考虑因素包括对研究重点和动机的评估,临床需求的清晰度和中心性,研究团队的专业和人口多样性,以及跨学科知识的产生和合作。受访者确定的第一阶段伦理问题本质上是跨学科的,并提出了有关如何在医疗人工智能和机器学习的开发和实施过程中协调跨学科的优先事项和价值观,并确保临床价值的问题。与此相关,受访者对这些问题提出了跨学科的解决方案,例如,提供更多资源来支持知识生成和开发人员与医生之间的协作;与更广泛的利益相关者合作,并努力增加研究的多样性。这些定性研究结果有助于阐明在医疗保健领域人工智能和机器学习中预期或遇到的几个伦理挑战。我们的研究是独一无二的,因为它使用开放式问题,允许受访者探索他们的情绪和观点,而不过度依赖于关于人工智能和机器学习目前是什么或不是什么的隐含假设。然而,该分析不包括其他相关利益相关者群体的观点,如患者、伦理学家、行业研究人员或代表,或医生以外的其他卫生保健专业人员。需要进行更多的定性和定量研究,以再现和巩固这些发现。
{"title":"Physicians' and Machine Learning Researchers’ Perspectives on Ethical Issues in the Development of Clinical Machine Learning Tools: A Qualitative Interview Study (Preprint)","authors":"Jane Paik Kim, Katie Ryan, Max Kasun, Justin Hogg, Laura B. Dunn, Laura W. Roberts","doi":"10.2196/47449","DOIUrl":"https://doi.org/10.2196/47449","url":null,"abstract":"Background Innovative tools leveraging artificial intelligence (AI) and machine learning (ML) are rapidly being developed for medicine, with new applications emerging in prediction, diagnosis, and treatment across a range of illnesses, patient populations, and clinical procedures. One barrier for successful innovation is the scarcity of research in the current literature seeking and analyzing the views of AI or ML researchers and physicians to support ethical guidance. Objective This study aims to describe, using a qualitative approach, the landscape of ethical issues that AI or ML researchers and physicians with professional exposure to AI or ML tools observe or anticipate in the development and use of AI and ML in medicine. Methods Semistructured interviews were used to facilitate in-depth, open-ended discussion, and a purposeful sampling technique was used to identify and recruit participants. We conducted 21 semistructured interviews with a purposeful sample of AI and ML researchers (n=10) and physicians (n=11). We asked interviewees about their views regarding ethical considerations related to the adoption of AI and ML in medicine. Interviews were transcribed and deidentified by members of our research team. Data analysis was guided by the principles of qualitative content analysis. This approach, in which transcribed data is broken down into descriptive units that are named and sorted based on their content, allows for the inductive emergence of codes directly from the data set. Results Notably, both researchers and physicians articulated concerns regarding how AI and ML innovations are shaped in their early development (ie, the problem formulation stage). Considerations encompassed the assessment of research priorities and motivations, clarity and centeredness of clinical needs, professional and demographic diversity of research teams, and interdisciplinary knowledge generation and collaboration. Phase-1 ethical issues identified by interviewees were notably interdisciplinary in nature and invited questions regarding how to align priorities and values across disciplines and ensure clinical value throughout the development and implementation of medical AI and ML. Relatedly, interviewees suggested interdisciplinary solutions to these issues, for example, more resources to support knowledge generation and collaboration between developers and physicians, engagement with a broader range of stakeholders, and efforts to increase diversity in research broadly and within individual teams. Conclusions These qualitative findings help elucidate several ethical challenges anticipated or encountered in AI and ML for health care. Our study is unique in that its use of open-ended questions allowed interviewees to explore their sentiments and perspectives without overreliance on implicit assumptions about what AI and ML currently are or are not. This analysis, however, does not include the perspectives of other relevant stakeholder groups, such as patients","PeriodicalId":73551,"journal":{"name":"JMIR AI","volume":"71 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136018661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JMIR AI
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1